Abstract
Metastatic progression in ductal breast carcinomas are related to apoptosis in primary tumors. Frameshift mutations in a single-repeat sequence within the coding region (G)8 of the pro-apoptotic Bax gene have been related to microsatellite instability (MSI) and progression of some carcinomas and lymphomas. The aim of this study was to explore whether the extended lifespan of breast cancer cells can also be triggered by Bax mutation in ductal-breast carcinomas, and whether breast cancer cell MSI is related to the loss of apoptosis. For this purpose we studied frameshift mutations of a microsatellite (G)8 in the third exon of the Bax gene in a series of 105 ductal breast carcinomas, at T1 and T2–3 stages, 45 of which had lymph node metastasis. We analyzed MSI in five sequences of DNA isolated from normal and tumor tissue samples taken from 86 patients, and we explored the relationship between MSI and tumor apoptosis status. Bax mutation was not present in ductal breast carcinomas. MSI (two or more markers altered) was detected in 11.6% of tumors. Loss of apoptosis occurred in 80% (8/10) tumors with MSI, versus 17.8% of tumors without MSI (χ2 test, p=0.0004), independently of Bax protein expression. We conclude that frameshift mutations of a microsatellite (G)8 of the Bax gene are not critical for the loss of apoptosis in breast cancer, and that loss of apoptosis may be a consequence of overexpression of anti-apoptotic protein Bcl-2 or Bcl-xL. Moreover, MSI in breast carcinomas might be the cause of loss of an apoptotic pathway that is not induced by frameshift mutations of a microsatellite (G)8 of the Bax gene.
References
van de Vijver MJ: Molecular genetic changes in human breast cancer. Adv Cancer Res 61: 25-56, 1993
Loeb LA: Microsatellite instability: Marker of a mutator phenotype in cancer. Cancer Res 54: 5059-5063, 1994
Bièche I, Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes & Cancer 14: 227-251, 1995
Dahiya R, Deng G: Molecular prognostic markers in breast cancer. Breast Cancer Res Treat 52: 185-200, 1998
Sierra A, Castellsagué X, Tórtola S, Escobedo A, Lloveras B, Peinado MA, Moreno A, Fabra A: Apoptosis loss and Bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Clin Cancer Res 2: 1887-1894, 1996
Cherbonnel-Lasserre C, Gauny S, Kronenberg A: Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis. Oncogene 13: 1489-1497, 1996
Yin DX, Schimke RT: Inhibition of apoptosis by overexpressing Bcl-2 enhances gene amplification by a mechanism independent of aphidicolin pretreatment. Proc Natl Acad Sci USA 93: 3394-3398, 1996
Kroemer G: The proto-oncogen Bcl-2 and its role in regulating apoptosis. Nature Med 3: 614-620, 1997
Hockenbery DM: Bcl-2 in cancer, development and apoptosis. J Cell Sci 18: 51-55, 1994
Farrow SN, Brown R: New members of the Bcl-2 family and their protein partners. Curr Op Genet Develop 6: 45-49, 1996
Yang E, Korsmeyer SJ: Molecular thanatopsis: a discourse on the Bcl-2 family an cell death. Blood 88: 386-401, 1996
Minn AJ, Swain RE, Ma A, Thompson CB: Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv Immunol 70: 245-279, 1998
Nomura M, Shimizu S, Ito T, Narita M, Matsuda H, Tsujimoto Y: Apoptotic cytosol facilitates Bax tranlocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res 59: 5542-5548, 1999
Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E, Nordling S, Reed JC: Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55: 4471-4478, 1995
Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagener C, Kallinich B, Royer HD, Dörken B: Expression of the Bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 60: 854-859, 1995
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M: Somatic frameshift mutations in the Bax gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969, 1997
Brimmell M, Mendiola R, Mangion J, Packham G: Bax frameshift mutations in cell lines derived from human haemopoietic malignacies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16: 1803-1812, 1998
Wooster R, Clenton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BAJ, von Deimling A, Wiestler OD, Cornelisse CJ, Devilee P, Stratton MR: Instability of short tandem repeats (microsatellites) in human cancers. Nature Gen 6: 152-156, 1994
Patel U, Grundfest-Broniatowski S, Gupta M, Banerjee S: Microsatellite instabilities at five chromosomes in primary breast tumors. Oncogene 9: 3695-3700, 1994
Minobe K, Bando K, Fukino K, Soma S, Kasumi F, Sakamoto G, Furukawa K, Higuchi K, Onda M, Nakamura Y, Emi M: Somatic mutation of the PTEN/MNAC1 gene in breast cancers with microsatellite instability. Cancer Letters 144: 9-16, 1999
Siah SP, Quinn DM, Bennett GD, Casey G, Flower RL, Suthers G, Rudzki Z: Microsatellite instability markers in breast cancer: a review and study showing MSI was not detected at ‘BAT 25’ and ‘BAT 26’ microsatellite markers in early-onset breast cancer. Breast Cancer Res Treat 60: 135-142, 2000
Anbazhagan R, Fujii H, Gabrielson E: Microsatellite instability is uncommon in breast cancer. Clin Cancer Res 5: 839-844, 1999
Contegiacomo A, Palmirotta R, De Marchis L, Pizzi C, Mastranzo P, Del Rio P, Petrella G, Figliolini M, Bianco AR, Frati L, Cama A, Mariani-Costantini R: Microsatellite instability and pathological aspects of breast cancer. Int J Cancer 64: 264-268, 1995
Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M: Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 55: 3976-3981, 1995
De Marchis L, Contegiacomo A, D'Amico C, Palmirotta R, Pizzi C, Ottini L, Mastranzo P, Figliolini M, Petrella G, Amanti C, Battista P, Bianco AR, Frati L, Cama A, Mariani-Costantini R: Microsatellite instability is correlated with lymph node-positive breast cancer. Clin Cancer Res 3: 241-248, 1997
Sierra A, Castellsague X, Escobedo A, Lloveras B, García-Ramirez M, Moreno A, Fabra A: Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer. Int J Cancer 89: 142-147, 2000
Sierra A, Lloveras B, Castellsagué X, Moreno L, García-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60: 54-60, 1995
Sierra A, Castellsagué X, Escobedo A, Lloveras B, Moreno A, Fabra A: Expression of death-related genes and their relationship with loss of apoptosis in T1 ductal breast carcinomas. Int J Cancer 79: 103-110, 1998
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
Huang Y, Bove B, Wu Y, Russo IH, Yang X, Zekri A, Russo J: Microsatellite instability during the immortalization and transformation of human breast epithelial cells in vitro. Mol Carcinog 24: 118-127, 1999
Liu Y, Naumovski L, Hanawalt P: Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress Bcl-2. Cancer Res 57: 1650-1653, 1997
Yin C, Knudsor CM, Korsmeyer SJ, Van Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640, 1997
Walsh T, Chappell SA, Shaw JA, Walker RA: Microsatellite instability in ductal carcinoma in situ of the breast. J Pathol 185: 18-24, 1998
Ouyang H, Furukawa T, Abe T, Kato Y, Horii A: The Bax gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach and endometrium. Clin Cancer Res 4: 1071-1074, 1998
Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jäger R, Weiher H, Furth PA: Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59: 2541-2545, 1999
Liebermann DA, Hoffman B, Steinman RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199-210, 1995
Meijerink JPP, Mensink EJBM, Wang K, Sedlak TW, Slöetjes AW, de Witte T, Waksman G, Korsmeyer SJ: Hematopoietic malignancies demonstrate loss-of-function mutations of Bax. Blood 91: 2991-2997, 1998
Tomita S, Deguchi S, Miyaguni T, Muto Y, Tamamoto T, Toda T: Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features. Breast Cancer Res Treat 53: 33-39, 1999
Perucho M: Correspondence re: Boland CR et al.: National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998; Cancer Res 59: 249-253, 1999
Formantici C, Orlandi R, Ronchini C, Pilotti S, Ranzani GN, Colnaghi MI, Ménard S: Absence of microsatellite instability in breast carcinomas with both p53 and c-erbB-2 alterations. J Pathol 187: 424-427, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Méndez, O., Máñas, S., Peinado, M. et al. Microsatellite Instability is Associated with the Loss of Apoptosis in Ductal Breast Carcinomas. Breast Cancer Res Treat 65, 171–177 (2001). https://doi.org/10.1023/A:1006490622103
Issue Date:
DOI: https://doi.org/10.1023/A:1006490622103